<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ROP Archives - Phoenix-micron</title>
	<atom:link href="https://phoenixmicron.com/fr/tag/rop/feed/" rel="self" type="application/rss+xml" />
	<link>https://phoenixmicron.com/fr/tag/rop/</link>
	<description></description>
	<lastBuildDate>Thu, 02 Apr 2026 17:50:43 +0000</lastBuildDate>
	<language>fr-FR</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://phoenixmicron.com/wp-content/uploads/2023/11/Gold-and-White-Real-Estate-Agency-Logo-Template-1-150x150.png</url>
	<title>ROP Archives - Phoenix-micron</title>
	<link>https://phoenixmicron.com/fr/tag/rop/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Targeting VEGF164 in Müller cells may be useful to treat retinopathy of prematurity</title>
		<link>https://phoenixmicron.com/fr/targeting-vegf164-in-muller-cells-may-be-useful-to-treat-retinopathy-of-prematurity/</link>
		
		<dc:creator><![CDATA[Phoenix-Micron Team]]></dc:creator>
		<pubDate>Tue, 23 Jun 2020 22:42:59 +0000</pubDate>
				<category><![CDATA[fERG]]></category>
		<category><![CDATA[InSight]]></category>
		<category><![CDATA[Micron IV]]></category>
		<category><![CDATA[PTOM]]></category>
		<category><![CDATA[Non catégorisé]]></category>
		<category><![CDATA[anti-VEGF]]></category>
		<category><![CDATA[électrorétinographie]]></category>
		<category><![CDATA[ERG]]></category>
		<category><![CDATA[immunohistochimie]]></category>
		<category><![CDATA[ARNm]]></category>
		<category><![CDATA[Cellules de Müller]]></category>
		<category><![CDATA[Rétinopathie du prématuré]]></category>
		<category><![CDATA[ROP]]></category>
		<category><![CDATA[VEGF]]></category>
		<guid isPermaLink="false">https://phoenixmicrdev.wpengine.com/?p=3498</guid>

					<description><![CDATA[<p>In Nature’s Scientific Reports, Becker et al use the Phoenix MICRON® IV, OCT, and focal ERG to assess the therapeutic value of knocking down a splice variant of VEGF in Müller cells in a model of Retinopathy of Prematurity (ROP). ROP is characterized by delayed vascularization of the retina after disrupted oxygen levels, followed by [&#8230;]</p>
<p>The post <a href="https://phoenixmicron.com/fr/targeting-vegf164-in-muller-cells-may-be-useful-to-treat-retinopathy-of-prematurity/">Targeting VEGF&lt;sub&gt;164&lt;/sub&gt; in Müller cells may be useful to treat retinopathy of prematurity</a> appeared first on <a href="https://phoenixmicron.com/fr/">Phoenix-micron</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
